U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. Animal Model Qualification Program | AMQP
  6. The Animal Model Qualification Process
  1. Animal Model Qualification Program | AMQP

The Animal Model Qualification Process

Learn about the process and access submission content outlines

The qualification process comprises FDA review of specific documents submitted to the AMQP in three successive stages (i.e., Stage 1 – Letter of Intent, Stage 2 – Qualification Plan, and Stage 3 – Full Qualification Package).  

Outlines for the content of the Letter of Intent and Qualification Plan are provided in the links in the table below.  The contents of the Full Qualification Package will be determined based on discussions between the requestor and the AMQP.  Study reports submitted as part of the Full Qualification Package should be final study reports and include the study protocol and amendments, line listings for each data point for each animal, tabular summaries, and full data analyses.

Stage 1 Letter of Intent (PDF - 57KB)
Stage 2 Qualification Plan (PDF - 72KB)
Stage 3 Full Qualification Package
Back to Top